MicroRNA profiling of Chinese primary glioblastoma reveals a temozolomide-chemoresistant subtype
暂无分享,去创建一个
Pei Yang | Wei Yan | Tao Jiang | Zheng Wang | T. Jiang | Z. Wang | Y. You | Yan-wei Liu | Wei Yan | Yanwei Liu | Yongping You | Pei Yang
[1] Thomas D. Wu,et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.
[2] C. Ricketts,et al. Genome-wide DNA methylation profiling of CpG islands in breast cancer identifies novel genes associated with tumorigenicity. , 2011, Cancer research.
[3] M. Bushell,et al. microRNAs in cancer management. , 2012, The Lancet. Oncology.
[4] S. Gabriel,et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.
[5] R. Mirimanoff,et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. , 2005, The New England journal of medicine.
[6] Agnieszka Bronisz,et al. Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. , 2008, Cancer research.
[7] M. Nicholas,et al. Molecular heterogeneity in glioblastoma: therapeutic opportunities and challenges. , 2011, Seminars in oncology.
[8] W. Cavenee,et al. Heterogeneity maintenance in glioblastoma: a social network. , 2011, Cancer research.
[9] M. J. van den Bent,et al. Molecular targeted therapies and chemotherapy in malignant gliomas , 2007, Current opinion in oncology.
[10] Svetlana Kotliarova,et al. SnapShot: glioblastoma multiforme. , 2012, Cancer cell.
[11] Andrew P. Stubbs,et al. Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology. , 2009, Cancer research.
[12] Lajos Pusztai,et al. Chips to Bedside: Incorporation of Microarray Data into Clinical Practice , 2006, Clinical Cancer Research.
[13] Tae-Min Kim,et al. A developmental taxonomy of glioblastoma defined and maintained by MicroRNAs. , 2011, Cancer research.
[14] George Coukos,et al. Therapeutic MicroRNA Strategies in Human Cancer , 2009, The AAPS Journal.
[15] Pei Yang,et al. MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis , 2014, Oncotarget.
[16] L. Ricci-Vitiani,et al. Inhibition of DNA methylation sensitizes glioblastoma for tumor necrosis factor-related apoptosis-inducing ligand-mediated destruction. , 2005, Cancer research.
[17] T. Jiang,et al. Oncogene addiction in gliomas: Implications for molecular targeted therapy , 2011, Journal of experimental & clinical cancer research : CR.
[18] T. Jiang,et al. Whole‐genome microRNA expression profiling identifies a 5‐microRNA signature as a prognostic biomarker in Chinese patients with primary glioblastoma multiforme , 2013, Cancer.
[19] Lei Wang,et al. Correlation of IDH1 Mutation with Clinicopathologic Factors and Prognosis in Primary Glioblastoma: A Report of 118 Patients from China , 2012, PloS one.